Controlled nicorandil administration for myocardial protection during coronary artery bypass grafting under cardiopulmonary bypass

Journal of Cardiovascular Pharmacology

Volumn 38, Issue 1, 2001, Pages 21-28

  Hayashi, Yoshitaka ^a   Sawa, Yoshiki ^a   Ohtake, Shigeaki ^a   Nishimura, Motonobu ^a   Ichikawa, Hajime ^a   Matsuda, Hikaru ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Cardiopulmonary bypass; Coronary artery bypass grafting; Myocardial protection; Nicorandil; Potassium channel opener

Indexed keywords

CATECHOLAMINE; CREATINE KINASE MB; FATTY ACID BINDING PROTEIN; MALONALDEHYDE; NICORANDIL; POTASSIUM CHANNEL STIMULATING AGENT;

ADULT; AGED; ARTICLE; BOLUS INJECTION; CARDIOPLEGIA; CARDIOPULMONARY BYPASS; CLINICAL TRIAL; CONTINUOUS INFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DOSE RESPONSE; DRUG EFFECT; FEMALE; HEART BEAT; HEART MUSCLE REPERFUSION; HEART PROTECTION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; ST SEGMENT;

ADULT; AGED; AGED, 80 AND OVER; ANTI-ARRHYTHMIA AGENTS; CARDIOPULMONARY BYPASS; CHI-SQUARE DISTRIBUTION; CORONARY ARTERY BYPASS; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL CONTRACTION; MYOCARDIAL REPERFUSION INJURY; NICORANDIL;

EID: 0034939446     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-200107000-00003     Document Type: Article

References (35)

1. Mechanism of the vasodilatory action of nicorandil on coronary circulation in dogs
2. Vasodilatory effect of nicorandil on coronary arterial microvessels: Its dependency on vessel size and the involvement of the ATP-sensitive potassium channels
3. Prevention of coronary spasms during aorto-coronary (A-C) bypass surgery for variant angina and effort angina with ST-elevation
4. Diltiazem provides anti-ischemic and anti-arrhythmic protection in patients undergoing coronary bypass grafting
5. Paradoxical vasoconstriction induced by acetylcholine in arteriosclerotic coronary arteries
6. Role of impaired endothelium-dependent vasodilation in ischemic manifestations of coronary artery disease
7. Release of endothelium-derived relaxing factor is modulated both by frequency and amplitude of pulsatile flow
8. Coronary-artery spasm immediately after myocardial revascularization: Recognition and management
9. Effects of 2-nicotinamidethyl nitrate (SG-75) and/or nitroglycerin on systemic hemodynamics and coronary blood flow in conscious dogs
10. Effect of nicorandil on coronary spasm
11. Nicorandil: A review of its pharmacology and therapeutic efficacy in angina pectoris
12. Ischaemic preconditioning may abolish the protection afforded by ATP-sensitive potassium channel openers in isolated human atrial muscle
13. Myocardial protection afforded by nicorandil and ischaemic preconditioning in a rabbit infarct model in vivo
14. Protective effect of nicorandil as an additive to the solution for continuous warm cardioplegia
15. Activation of ATP-dependent K+ channels enhances myocardial protection due to cold high potassium cardioplegia: A force-frequency relationship study
16. Potassium channel openers prevent potassium-induced calcium loading of cardiac cells: Possible implications in cardioplegia
17. Hyperpolarized cardioplegic arrest with nicorandil: Advantages over other potassium channel openers
18. Elective cardiac arrest with a hyperpolarizing adenosine triphosphate-sensitive potassium channel opener: A novel form of myocardial protection
19. Preconditioning protects ischemic rabbit heart by protein kinase C activation
20. ATP channels: Triggers or distal effectors of ischemic or pharmacological preconditioning?
21. ATP channels: Probing molecular identity and pharmacology
22. Attenuation of cardiopulmonary bypass-derived inflammatory reactions reduces myocardial reperfusion injury in cardiac operations
23. Clinical evaluation of leukocyte-depleted blood cardioplegia for pediatric open heart operation
24. Evaluation of leukocyte-depleted terminal blood cardioplegic solution in patients undergoing elective and emergency coronary artery bypass grafting
25. Clinical profile of nicorandil: An overview of its hemodynamic properties and therapeutic efficacy
26. Myocardial release of malondialdehyde and purine compounds during coronary bypass surgery
27. Early detection of cardiac damage with heart fatty acid-binding protein after cardiac operations
28. Evaluation of serum creatine kinase and lactate dehydrogenase in experimental myocardial infarction, atriotomies, and thoracotomies
29. Temperature-specific effects of adjuvant diltiazem therapy on myocardial energetics following potassium cardioplegic arrest
30. Amelioration of postischemic stunning by deferoxamine-blood cardioplegia
31. Adjuvant N-(2-mercaptopropionyl)-glycine in blood cardioplegia does not improve myocardial protection in ischemically damaged hearts
32. Acadesine improves surgical myocardial protection with blood cardioplegia in ischemically injured canine hearts
33. Release of vasoactive substances during cardiopulmonary bypass
34. Analysis of coronary responses to nifedipine alone and in combination with intracoronary nitroglycerin in patients with coronary artery disease
35. Protective effects of ATP sensitive potassium channel openers in models of myocardial ischemia